{"product_id":"elevancehealth-five-forces-analysis","title":"Elevance Health Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDon't Miss the Bigger Picture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eElevance Health faces intense buyer bargaining, regulatory pressure, and competitive rivalry from insurers and tech-enabled entrants, while supplier leverage and substitute care models shape margins and growth. This snapshot highlights key tensions but omits force-by-force ratings, visuals, and actionable recommendations. Unlock the full Porter's Five Forces Analysis to get a consultant-grade breakdown for strategy or investment decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidated hospital systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLarge consolidated hospital systems extract leverage over Elevance—which serves about 46 million members in 2024—by owning must-have facilities and branded centers of excellence, prompting Elevance to pursue multi-year contracts and steerage to control costs; in concentrated metros hospital unit prices can be 10–30% higher. Narrow and tiered networks help rebalance power but access standards and member expectations limit exclusions, while rate disputes risk network disruption and mutual concessions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialist and primary care shortages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eProvider scarcity in behavioral health, oncology and select PCP markets raises fee pressure; in 2024 roughly 40% of US counties lack a psychiatrist and average new‑patient PCP waits are about 24 days. Elevance leans on value‑based contracts and a ~30% lift in virtual visits versus 2020 to expand supply, but credentialing and quality guardrails slow scaling. Extended waits erode payer leverage on utilization controls; incentives and care management mitigate but do not eliminate supplier power.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma manufacturers and specialty drugs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh-cost biologics and limited‑competition therapies push supplier power higher, with specialty drugs accounting for roughly 50% of US drug spending as of 2024 and single-dose gene therapies like Zolgensma priced at about $2.1M maintaining manufacturer leverage.\u003c\/p\u003e\n\u003cp\u003eFormulary design, prior authorization and rising biosimilar uptake contain costs but face clinical and regulatory limits that slow savings realization.\u003c\/p\u003e\n\u003cp\u003eElevance’s integrated pharmacy services, serving ~48 million members, strengthen rebate capture and data‑driven management, yet orphan drugs and novel gene therapies keep pricing power skewed to manufacturers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePBM, data, and tech vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eInteroperability, claims platforms, analytics and cybersecurity are mission-critical for Elevance, creating high switching frictions; Elevance reported about $150B revenue in 2024, enabling strong in-house build and bargaining leverage. Niche PBM, data and tech vendors retain pricing power for specialized tools and data sets. Long implementation cycles (18–36 months) and compliance needs further entrench suppliers. Co-development deals often trade margin for faster innovation.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSwitching friction: high\u003c\/li\u003e\n\u003cli\u003eIn-house build: reduces dependence\u003c\/li\u003e\n\u003cli\u003eImplementation: 18–36 months\u003c\/li\u003e\n\u003cli\u003eCo-dev: margin for speed\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eReinsurance and ancillary services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eReinsurance and stop-loss markets materially affect Elevance Health’s capital efficiency and risk appetite; tightened capacity and hard market pricing since 2023 have raised ceded costs and shifted leverage toward reinsurers. Ancillary networks (dental, vision, behavioral) can exert local bargaining power where options are scarce, though Elevance’s scale and multi-line bundling mitigate single-supplier pressure. Elevance served about 48 million members in 2024, enhancing bundling leverage.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eReinsurance hardening → higher ceded cost, lower capital efficiency\u003c\/li\u003e\n\u003cli\u003eAncillary networks strong in limited local markets\u003c\/li\u003e\n\u003cli\u003eMulti-line bundling with ~48M members offsets supplier power\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier power squeezes margins despite scale; \u003cstrong\u003e46M\u003c\/strong\u003e medical, \u003cstrong\u003e48M\u003c\/strong\u003e pharmacy, \u003cstrong\u003e$150B\u003c\/strong\u003e revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSupplier power is elevated: hospital concentration, specialty drug pricing and provider scarcity constrain Elevance’s margins despite scale; Elevance served ~46M medical and ~48M pharmacy members in 2024 and reported ~$150B revenue. Value‑based contracts and in‑house tech reduce dependence but long vendor cycles (18–36 months) and orphan drugs keep leverage with suppliers. Reinsurance hardening since 2023 raised ceded costs.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMembers (medical)\u003c\/td\u003e\n\u003ctd\u003e~46M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePharmacy reach\u003c\/td\u003e\n\u003ctd\u003e~48M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e~$150B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty drug share\u003c\/td\u003e\n\u003ctd\u003e~50% of drug spend\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCounties w\/o psychiatrist\u003c\/td\u003e\n\u003ctd\u003e~40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored Porter’s Five Forces analysis of Elevance Health assessing competitive rivalry, buyer and supplier power, threat of substitutes and new entrants, and identifying disruptive trends and regulatory barriers that shape pricing, margins and strategic positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eClear one-sheet Porter's Five Forces for Elevance Health—instantly visualizes competitive pressure with a spider chart and customizable intensity levels, ready to drop into decks or Excel dashboards to relieve analysis bottlenecks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge employer groups\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLarge national and jumbo employer groups negotiate aggressively on premiums, ASO fees and performance guarantees, leveraging multi-carrier bids and broker benchmarking while favoring custom networks and stop-loss to shift risk. In 2024 Elevance served about 47 million members and reported roughly $169 billion in revenue, countering with integrated benefits, advanced analytics and value-based outcome commitments to retain large accounts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment programs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMedicaid and Medicare Advantage buyers are highly price sensitive and tightly regulated, with Medicaid\/CHIP covering ~82 million people and MA enrollment ~31.5 million in 2024, intensifying procurement pressure on margins. States' competitive solicitations and network rules compress rates, while CMS links MA payments to star ratings and risk scores, giving regulators indirect control over plan design. Loss of a state contract or a star downgrade can shift millions of members rapidly, hitting revenue and margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eACA individual members\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eACA individual members show high price elasticity: roughly 15 million marketplace enrollees in 2024 and about 80% receiving premium subsidies drive sensitivity to premium changes. Annual open enrollment and plan switching, especially in counties with multiple carriers, increase buyer leverage. Network breadth and deductible levels are primary differentiators, and comparison tools\/aggregators accelerate switching, compressing industry margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrokers and consultants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eBrokers and consultants significantly shape employer plan selection, demanding fee concessions, custom reporting and performance guarantees to secure placements. Their market-wide visibility and access to multiple carriers strengthens negotiating positions, forcing Elevance to offer clinical program commitments and outcomes-based terms. Elevance offsets this by investing in distribution enablement to maintain shelf space and broker loyalty.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eIntermediary leverage: fee concessions, reporting\u003c\/li\u003e\n\u003cli\u003eNegotiation power: market visibility, multi-carrier access\u003c\/li\u003e\n\u003cli\u003eWin criteria: performance guarantees, clinical programs\u003c\/li\u003e\n\u003cli\u003eElevance response: distribution enablement investments\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSwitching costs and experience\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eWhile member disruption and provider continuity create switching frictions for Elevance Health, annual renewal cycles reopen choices; Elevance served about 48 million members in 2024, so even small churn shifts large volumes. Poor service or narrow network changes have historically triggered spikes in attrition, while improved digital engagement and care management programs lift loyalty and reduce buyer power. Competitive parity in benefits and networks erodes differentiation if not continuously refreshed.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e48 million members in 2024 — scale magnifies churn impact\u003c\/li\u003e\n\u003cli\u003eRenewals = recurring choice points\u003c\/li\u003e\n\u003cli\u003eDigital\/care mgmt reduces churn\u003c\/li\u003e\n\u003cli\u003eNetwork\/service shifts can trigger churn\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuyers wield leverage: employers, brokers and public programs squeeze premiums\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBuyers exert strong leverage: large employers demand lower premiums, ASO concessions and guarantees; brokers amplify this through multi-carrier bids. Medicaid\/MA and marketplace programs (82M Medicaid\/CHIP, 31.5M MA, 15M marketplace in 2024) press pricing via regulation and subsidies. Elevance (≈48M members, $169B revenue in 2024) counters with integrated benefits, analytics and value-based contracts.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMembers\u003c\/td\u003e\n\u003ctd\u003e≈48M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$169B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicaid\/CHIP\u003c\/td\u003e\n\u003ctd\u003e≈82M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare Advantage\u003c\/td\u003e\n\u003ctd\u003e≈31.5M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarketplace enrollees\u003c\/td\u003e\n\u003ctd\u003e≈15M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eElevance Health Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Elevance Health Porter’s Five Forces analysis you’ll receive immediately after purchase—no surprises, no placeholders. The file is the complete, professionally formatted report, ready for download and immediate use. It comprehensively covers competitive rivalry, supplier and buyer power, threat of entry, and substitutes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56162858959225,"sku":"elevancehealth-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/elevancehealth-five-forces-analysis.png?v=1762710073","url":"https:\/\/portersfiveforce.com\/products\/elevancehealth-five-forces-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}